Barbed suture for vaginal cuff closure in laparoscopic hysterectomy

JSLS. 2014 Jan-Mar;18(1):83-8. doi: 10.4293/108680813X13693422518795.

Abstract

Background and objectives: Our aim was to evaluate whether the use of barbed suture for vaginal cuff closure is associated with a decrease in postoperative vaginal bleeding compared with cuff closure with polyglactin 910 in patients who have undergone laparoscopic hysterectomy.

Methods: We performed a cohort study of patients who underwent laparoscopic hysterectomy between January 2008 and July 2012 by the minimally invasive gynecologic surgery division of the Gynecology, Obstetrics and Human Reproduction Department at Fundación Santa Fe de Bogotá University Hospital, Bogotá, Colombia.

Results: A total of 232 women were studied: 163 were in the polyglactin 910 group, and 69 were in the barbed suture group. The main outcome, postoperative vaginal bleeding, was documented in 53 cases (32.5%) in the polyglactin 910 group and in 13 cases (18.8%) in the barbed suture group (relative risk, 0.57; 95% confidence interval, 0.34-0.9; P = .03). No statistically significant differences were found in other postoperative outcomes, such as emergency department admission, vaginal cuff dehiscence, infectious complications, and the presence of granulation tissue.

Conclusion: In this study an inverse association was observed between the use of barbed suture for vaginal cuff closure during laparoscopic hysterectomy and the presence of postoperative vaginal bleeding.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Colombia / epidemiology
  • Equipment Design
  • Female
  • Follow-Up Studies
  • Humans
  • Hysterectomy / methods*
  • Incidence
  • Laparoscopy / methods*
  • Middle Aged
  • Polyglactin 910*
  • Postoperative Hemorrhage / epidemiology
  • Postoperative Hemorrhage / prevention & control*
  • Retrospective Studies
  • Suture Techniques / instrumentation*
  • Sutures
  • Treatment Outcome
  • Uterine Hemorrhage / epidemiology
  • Uterine Hemorrhage / prevention & control*
  • Vagina / surgery*

Substances

  • Polyglactin 910